HCA Healthcare (HCA)
(Delayed Data from NYSE)
$356.97 USD
+2.98 (0.84%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $357.15 +0.18 (0.05%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth A Momentum A VGM
Fundamental Charts
About Market Cap
As of the previous market close, HCA Healthcare, Inc. has a market cap of $85.16B, which represents its share price of $353.99 multiplied by its outstanding shares number of 240.57M. As a large-cap company, HCA's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
HCA 356.97 +2.98(0.84%)
Will HCA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for HCA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for HCA
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
HUM Misses Q2 Earnings on Higher Benefit Costs, Ups '25 EPS View
HCA: What are Zacks experts saying now?
Zacks Private Portfolio Services
ENSG's Q2 Earnings Beat on Higher Occupancy Rates, Stock Up 9%
HCA Beats Q2 Earnings on Higher Admissions, Ups '25 EPS View
HCA Healthcare (HCA) Beats Q2 Earnings and Revenue Estimates
Other News for HCA
Notable healthcare headlines for the week: Trump’s ultimatum to big pharma, Novo Nordisk, UnitedHealth and Moderna in focus
Here's How Much $1000 Invested In HCA Healthcare 5 Years Ago Would Be Worth Today
HCA Healthcare (HCA) Target Price Lowered by Barclays Analyst | HCA Stock News
RBC Capital Lowers Price Target for HCA Healthcare (HCA) | HCA Stock News
Morgan Stanley Revises Price Target for HCA (HCA) | HCA Stock News